Las Vegas, NV -- (SBWIRE) -- 10/17/2012 -- Nabi Biopharmaceuticals (NASDAQ:NABI) shares climbed 2.84% to $1.81 in the early hour after the company announced that the phase II study of NicVAX (Nicotine Conjugate Immunotherapeutic) in combination with varenicline (Chantix or Champix) did not meet its primary endpoint. The study which included 558 subjects in the Netherlands was a double-blinded, placebo-controlled trial with one arm treated with NicVAX plus varenicline and the other arm treated with placebo plus varenicline.
Will NABI Continue to Jump? Get Our Special Report To Get complete technical analysis on NABI go click my link
Advantage Oil & Gas Ltd (USA)(NYSE:AAV) shares jumped 3.37% to $3.99 in the early hour. The company, last month, announced that at the special meeting of shareholders of Advantage, shareholders approved the adoption by Advantage of a stock option plan. The stock option plan provides for long-term equity based compensation for directors, officers and employees of, and consultants to Advantage.
To Get complete technical analysis on AAV go click my link
Baidu.com, Inc. (ADR)(NASDAQ:BIDU) shares increased 1.08% to $114.61 after the company, this week, announced the release of Baidu PC Faster 2.0, its comprehensive PC security and optimization software, for the Thai market.
Additionally, the company announced that it will report its financial results for the third quarter ended September 30, 2012, after the U.S. market closes on October 29, 2012. Baidu's management will hold an earnings conference call at 8:00 PM on October 29, 2012 U.S. Eastern Time (8:00 AM on October 30, 2012 Beijing/Hong Kong Time).
Will BIDU Continue to Jump? Get Our Special Report To Get complete technical analysis on BIDU go click my link
Lions Gate Entertainment Corp. (USA)(NYSE:LGF) shares gained 1.89% to $15.66 in the morning hour. The company, on Oct. 5, announced the appointment of Brian Goldsmith as Co-Chief Operating Officer of the company. Goldsmith joins co-COO Steve Beeks in reporting to Lionsgate Chief Executive Officer Jon Feltheimer on corporate management issues, and will also continue to work closely with Vice Chairman Michael Burns and General Counsel Wayne Levin on M&A activities and initiatives related to the company's capital structure, including significant corporate and project financings.
To Get complete technical analysis on LGF go click my link
Pluristem Therapeutics Inc. (NASDAQ:PSTI) stock gained 1.28% to $4.01 after the company announced that a reduction of fibrotic processes has been demonstrated in preclinical and in in-vitro studies using Pluristem's Placental eXpanded (PLX) cells. Lena Pinzur MSc, Pluristem's Basic and Preclinical Research Manager will present data at the 3rd Annual Meeting of the Israel Society for Placenta Research on October 18, 2012.
To Get complete technical analysis on PSTI go click my link
About Cogo News
Cogonews.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by cogonews.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. cogonews.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)